Hematology.mx .-Haemostasis Science Weeks is a series of free online scientific conferences where leading hemostasis professionals from around the world shared their scientific insights on current clinical practice, developments, and next steps in testing this topic. It is organized by Siemens Healthineers within the framework of the World Day to Combat Thrombosis, commemorated on October 13.
To stay ahead of trends and developments, the company invites you to review the sessions on the topics: Coagulopathy associated with COVID-19, Monitoring of the patient with bleeding, Haemostasis tests in cardiovascular diseases, Monitoring of hemostasis in pregnancy and obstetrics, New insights into the mechanisms and management of hemostasis.
Thrombosis is characterized by the formation of clots within the blood vessels, where the blood in a liquid state turns into a thicker form of cells and other elements, which can partially or totally obstruct the vessels.
According to world estimates, in Mexico there may be between 400 and 500 thousand cases of thrombosis per year and, according to WorldThrombosisDay.org, one in four people worldwide dies due to a thrombosis, which often occurs in a silent. Therefore, it is intended to inform more people so that they understand the disease, the risk factors and their prevention.
In this sense, there are Arterial Thrombosis and Venous Thrombosis, although both are in the context of circulation, they have very particular characteristics.
Arterial thrombosis: shows a predominance of platelets, which generally settle on a plaque of calcium or fat. Clots that form within the heart can pass into the circulation and block a distant artery, a process called embolism, and can cause a stroke, heart attack, and gangrene of the extremities.
Venous thrombosis: obstruction of the secondary or main veins, which preferentially affects the lower extremities and, in most cases, is associated with risk factors. This type of thrombosis usually causes swelling and pain in the extremities, the larger the affected vein, the greater the clinical repercussion. The clots that form in the veins have a predominance of blood cells linked to clotting factors, the detachment of fragments can reach the lungs, causing a pulmonary embolism (PE). Deep vein thrombosis (DVT), unlike arterial thrombosis, rarely causes the loss of a limb, however, it is a disease that begins silently and can be fatal.
Hematology helps with platelet count and hemostasis with special tests. Platelets help stop bleeding when you have a wound, they stick together forming a kind of “network” to stop bleeding. However, substances released by the wound plus compounds carried by platelets can form a clot. The platelet count is done on a hematology machine.
The main risk factors are: obesity; the use of estrogen-based medications, such as female contraceptives; the postpartum period; to smoke; family history of VTE; prolonged immobility; long periods of hospitalization, cancer; some hit, among others.
At present, venous thromboembolism (VTE) can be considered a public health problem, so it is important that health professionals are prepared to recommend a clinical evaluation to those patients who have undergone surgery, who have a long period hospitalization or have a family history.
To attend the conferences on the subject, enter the link: https://www.siemens-healthineers.com/mx/news-and-events/conferences-events-new/hemostasis-science-weeks